+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bristol-Myers Squibb - logo

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

Company Snapshots: UK Pharmaceuticals - Product Thumbnail Image

Company Snapshots: UK Pharmaceuticals

  • Newsletter
  • October 2026
  • 35 Pages
  • United Kingdom
From
Company Snapshots: US Pharmaceuticals - Product Thumbnail Image

Company Snapshots: US Pharmaceuticals

  • Newsletter
  • October 2026
  • 35 Pages
  • United States
From
Bacterial Vaccines Market - Global Strategic Business Report - Product Thumbnail Image

Bacterial Vaccines Market - Global Strategic Business Report

  • Report
  • October 2026
  • 490 Pages
  • Global
From
From
From
T-cell Lymphoma Market 2024-2028 - Product Thumbnail Image

T-cell Lymphoma Market 2024-2028

  • Report
  • August 2024
  • 135 Pages
  • Global
From
Non-hodgkin Lymphoma (NHL) Therapeutics Market 2024-2028 - Product Thumbnail Image

Non-hodgkin Lymphoma (NHL) Therapeutics Market 2024-2028

  • Report
  • July 2024
  • 190 Pages
  • Global
From
Diuretics Market Report 2026 - Product Thumbnail Image

Diuretics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Breast Cancer Therapeutics Market 2024-2028 - Product Thumbnail Image

Breast Cancer Therapeutics Market 2024-2028

  • Report
  • January 2024
  • 168 Pages
  • Global
From
Chronic Lymphocytic Leukemia- Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Lymphocytic Leukemia- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 210 Pages
  • Global
From
Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Insight, 2025 - Product Thumbnail Image

Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator